BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 9274636)

  • 21. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
    Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
    Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of intramolecular epitope spreading in pemphigus vulgaris.
    Salato VK; Hacker-Foegen MK; Lazarova Z; Fairley JA; Lin MS
    Clin Immunol; 2005 Jul; 116(1):54-64. PubMed ID: 15925832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
    España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
    Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tryptic cleavage product of the mature form of the bovine desmoglein 1 ectodomain is one of the antigen moieties immunoprecipitated by all sera from symptomatic patients affected by a new variant of endemic pemphigus.
    Abréu-Vélez AM; Javier Patiño P; Montoya F; Bollag WB
    Eur J Dermatol; 2003; 13(4):359-66. PubMed ID: 12948916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
    Femiano F
    Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris.
    Müller R; Svoboda V; Wenzel E; Gebert S; Hunzelmann N; Müller HH; Hertl M
    Exp Dermatol; 2006 Aug; 15(8):606-14. PubMed ID: 16842599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ultrastructural localisation of pemphigus vulgaris and pemphigus foliaceus antigens by indirect immunoelectron microscopy. Apropos of 7 cases].
    Boulinguez S; Bedane C; Cadilhac H; Grolleau-Rochiccioli P; Caux F; Oksman F; Bonafé JL
    Ann Dermatol Venereol; 1995; 122(6-7):417-21. PubMed ID: 8526424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3).
    Memar O; Christensen B; Rajaraman S; Goldblum R; Tyring SK; Brysk MM; McCormick DJ; el-Zaim H; Fan JL; Prabhakar BS
    J Immunol; 1996 Oct; 157(7):3171-7. PubMed ID: 8816430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five Japanese cases of antidesmoglein 1 antibody-positive and antidesmoglein 3 antibody-negative pemphigus with oral lesions.
    Koga H; Ohyama B; Tsuruta D; Ishii N; Hamada T; Dainichi T; Natsuaki Y; Sogame R; Fukuda S; Karashima T; Tada J; Yamashiro M; Uezato H; Chan PT; Hashimoto T
    Br J Dermatol; 2012 May; 166(5):976-80. PubMed ID: 22242828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
    Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
    J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
    Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
    Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
    J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus.
    Amagai M; Komai A; Hashimoto T; Shirakata Y; Hashimoto K; Yamada T; Kitajima Y; Ohya K; Iwanami H; Nishikawa T
    Br J Dermatol; 1999 Feb; 140(2):351-7. PubMed ID: 10233237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
    Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of pemphigus vulgaris showing reactivity with pemphigus antigens (Dsg1 and Dsg3) and desmocollins.
    Hashimoto T; Amagai M; Watanabe K; Dmochowski M; Chidgey MA; Yue KK; Garrod DR; Nishikawa T
    J Invest Dermatol; 1995 Apr; 104(4):541-4. PubMed ID: 7706774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels.
    Harman KE; Seed PT; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
    Br J Dermatol; 2001 Apr; 144(4):775-80. PubMed ID: 11298536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraneoplastic pemphigus with circulating antibodies directed exclusively against the pemphigus vulgaris antigen desmoglein 3.
    Bouloc A; Joly P; Saint-Leger E; Wechsler J; Roujeau JC; Revuz J
    J Am Acad Dermatol; 2000 Oct; 43(4):714-7. PubMed ID: 11004638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of desmoglein 1 as autoantigen in a patient with intraepidermal neutrophilic IgA dermatosis type of IgA pemphigus.
    Kárpáti S; Amagai M; Liu WL; Dmochowski M; Hashimoto T; Horváth A
    Exp Dermatol; 2000 Jun; 9(3):224-8. PubMed ID: 10839721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgA pemphigus reacting exclusively to desmoglein 3.
    Tajima M; Mitsuhashi Y; Irisawa R; Amagai M; Hashimoto T; Tsuboi R
    Eur J Dermatol; 2010; 20(5):626-9. PubMed ID: 20605770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.